Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising progress across several clinical and industrial applications. With its structural similarity to The natural way derived human serum albumin, OsrHSA presents a safer, additional trusted choice for therapeutic use, notab